Cargando…
Patient-derived models: Advanced tools for precision medicine in neuroblastoma
Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the...
Autores principales: | Aaltonen, Kristina, Radke, Katarzyna, Adamska, Aleksandra, Seger, Alexandra, Mañas, Adriana, Bexell, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910084/ https://www.ncbi.nlm.nih.gov/pubmed/36776363 http://dx.doi.org/10.3389/fonc.2022.1085270 |
Ejemplares similares
-
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
por: Mañas, Adriana, et al.
Publicado: (2022) -
Anti-tumor effects of rigosertib in high-risk neuroblastoma
por: Radke, Katarzyna, et al.
Publicado: (2021) -
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
por: Valind, Anders, et al.
Publicado: (2023) -
Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017) -
Editorial: Radiomics Advances Precision Medicine
por: Gao, Bo, et al.
Publicado: (2022)